Technology company Intellego has started negotiations with a subsidiary of one of the world's largest pharmaceutical companies from the United States. This is stated in a press release.

The customer has evaluated Intellego's UV LED dosimeter and the market over the past nine months, with positive results. The goal of the collaboration is now to launch the dosimeter, and potentially other dosimeter products, on the global market, which is estimated to be worth EUR 2 billion per year.

The launch is planned for 2025, with sales expected to increase gradually over time.